Preclinical research market
The preclinical market currently represents all of Aiforia’s sales in addition to which Aiforia is now entering the clinical market. The preclinical industries include contract research organizations (CROs), pharmaceutical, biotechnology companies, as well as academic institutes seeking solutions for both medical research and education.
Aiforia offers both ready-to-use software as well as services for this market. Customers can create their own AI models with the intuitive Aiforia Create cloud-based platform which requires no coding or prior knowledge of AI or computing for customers to get started. The company also offers bespoke services in which Aiforia’s expert team of scientists create an AI model to meet the specific needs of the customer.
The value creation that Aiforia’s tools and services may provide in these industries is uniform across the different uses in preclinical research by not only increasing the speed, accuracy, and consistency of image analysis. This in turn would create value to the individual, the organization, and the healthcare industry as a whole — through the discovery of new prognostic markers for illnesses, the production of novel molecules to treat disease, and so much more.
Accelerating drug development
Aiforia enables CROs, pharmaceutical, and biotechnology companies to save on time and costs involved in preclinical and investigational analysis.
Aiforia also helps in maximizing the capabilities of these organization’s scientists and pathologists not only by providing tools that provide more accurate data but with cloud solutions that enable remote working and consultation.
Enhancing medical research
Aiforia supports academic customers in making new discoveries, producing quantitative results, and automating manual tasks thereby speeding up research and time to publication, as well as providing a cloud-based software through which researchers can work remotely or collaborate with colleagues in different locations.
Aiforia also offers a cloud-based platform, Aiforia Hub, for remote teaching across a wide range of disciplines integral to medical studies, such as pathology, parasitology and more. The education platform is used by some of the world’s leading research institutes. Aiforia Hub allows teachers and students to unbind themselves from microscopes, physical classrooms, and printed materials. The significant demand has continued to grow for these solutions during the COVID-19 pandemic.
Clinical diagnostics market
The established customer base in the preclinical market has created a base for Aiforia’s entry into the clinical market and Aiforia has through its customers and biobank access gained extensive amounts of data to help its clinical AI model development. The company is now entering the clinical market and aims to have several CE-IVD-marked AI models for different diseases and diagnostic tasks.
For clinical pathology labs looking to increase productivity and improve diagnostic accuracy, the Aiforia Clinical Suites are intended to offer AI-supported diagnostics, intelligent visualization, automated screening and reporting tools. With the Aiforia Clinical Suite pathologists could be able to harness both the full benefits of a digitized workflow and the full potential of their own expertise by automating repetitive tasks, increasing the speed and accuracy of case review thereby enabling labs to diagnose more patients in less time.
Opportunities outside of medical imaging
Aiforia’s products and technology are agile. The software is image agnostic, meaning any 2D image can be analyzed with Aiforia’s image analysis tools and setting up the opportunity for potential pivots. While a focus on medical images is concentrated, Aiforia’s software solutions are also used for a vast number of applications in non-medical domains. AI models have been created to analyze salmon skin, concrete slabs, satellite images and more.